The pogress at European Association of Urology (EAU)

EAU2023 has come to an end. Scientific sessions demonstrated the constant and solid progress EchoLaser is making as a game changer for the treatment of BPH: The first randomized clinical trial vs TURP shows that 96% of the patients treated with EchoLaser were able to...

EchoLaser SoracteLite TPLA: now on RAI national TV

TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology. Prof. Bove was one of the first users of EchoLaser and is the principal...

SoracteLite in UK

Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years. Patients can scan a QR Code and book a free...

EchoLaser and Sutton United

Our UK/IRE distributor Ideal Medical Systems (www.ideal-ms.com), advertised EchoLaser for BPH treatment with a dedicated signage at the stadium used by the UK football team Sutton United. This initiative will increase awareness on the newest non surgical alternative...

SIU-Italin Society of Urology

Discover about EchoLaser Soractelite at SIU congress in Riccione! a innovative microinvasive and transperineal treatment for BPH and PCa! Meet us in front of the bar at first floor or meet our expert on 17th October in Giulinai Room: NEW FRONTIERS IN MINIMALLY...